WO2003106624A3 - Cancer-linked gene as target for chemotherapy - Google Patents
Cancer-linked gene as target for chemotherapy Download PDFInfo
- Publication number
- WO2003106624A3 WO2003106624A3 PCT/US2003/018431 US0318431W WO03106624A3 WO 2003106624 A3 WO2003106624 A3 WO 2003106624A3 US 0318431 W US0318431 W US 0318431W WO 03106624 A3 WO03106624 A3 WO 03106624A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- target
- disclosed
- chemotherapy
- linked gene
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003245448A AU2003245448A1 (en) | 2002-06-13 | 2003-06-11 | Cancer-linked gene as target for chemotherapy |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38867202P | 2002-06-13 | 2002-06-13 | |
US60/388,672 | 2002-06-13 | ||
US39796602P | 2002-07-23 | 2002-07-23 | |
US60/397,966 | 2002-07-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003106624A2 WO2003106624A2 (en) | 2003-12-24 |
WO2003106624A3 true WO2003106624A3 (en) | 2004-12-09 |
Family
ID=29740051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/018431 WO2003106624A2 (en) | 2002-06-13 | 2003-06-11 | Cancer-linked gene as target for chemotherapy |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003245448A1 (en) |
WO (1) | WO2003106624A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876996A (en) * | 1997-07-25 | 1999-03-02 | Incyte Pharmaceuticals, Inc. | Human S-adenosyl-L-methionine methyltransferase |
-
2003
- 2003-06-11 WO PCT/US2003/018431 patent/WO2003106624A2/en not_active Application Discontinuation
- 2003-06-11 AU AU2003245448A patent/AU2003245448A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876996A (en) * | 1997-07-25 | 1999-03-02 | Incyte Pharmaceuticals, Inc. | Human S-adenosyl-L-methionine methyltransferase |
Also Published As
Publication number | Publication date |
---|---|
AU2003245448A8 (en) | 2003-12-31 |
WO2003106624A2 (en) | 2003-12-24 |
AU2003245448A1 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003105758A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003104399A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003097803A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003101400A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2008020596A3 (en) | Treating or preventing cancers over-expressing reg4 or kiaa0101 | |
WO2005077091A3 (en) | Nicotinamide riboside kinase compositions and methods for using the same | |
WO2007113648A3 (en) | Ctla4 antibody combination therapy | |
WO2003072125A8 (en) | Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides | |
EP1004022A4 (en) | Methods and compositions for overcoming resistance to biologic and chemotherapy | |
CR20220317A (en) | Anti-cd73 antibodies and uses thereof | |
MX2009013646A (en) | Methods of diagnosing and treating cancer. | |
PL335334A1 (en) | Combined treatment involing suppressor gene tumour therapy and chemotherapy for use in antineoplastic therapy | |
WO2005120588A3 (en) | Peptides delivered to cell nuclei | |
WO2004078215A3 (en) | Use of antibody conjugated deoxycytidine kinase for adept | |
MXPA05011085A (en) | Compositions and methods relating to stop-1. | |
WO2003104401A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003104438A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003076579A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003097802A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2002031198A3 (en) | Cancer-linked genes as targets for chemotherapy | |
WO2003105783A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2005079490A3 (en) | Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides | |
WO2004026238A8 (en) | Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers | |
WO2003104419A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003104404A8 (en) | Cancer-linked gene as target for chemotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |